(1.5 CME) In this conference recording from the 2019 Annual Conference, you will learn:
six award winning abstracts from the 2019 Annual Conference Call for
Abstracts will be presented at this fast-paced session. These abstracts were
the highest scoring abstracts in their respective categories. Presenters will
discuss their original research and take questions from the audience.
Awardees will receive their awards at the end of the session.
Award Winning Posters are as follows:
Implementation of a Buprenorphine Clinic at an Internal Medicine Resident
Teaching PCMH �" Seth A. Clark, MD, MPH; Award Winner:
DSM-5 Alcohol Use Disorder Severity and Sexual Orientation Discrimination:
A National Study �" Sean Esteban McCabe, PhD, MSW; Award Winner: Underserved Population
Perceived Quality Of Sleep During Substance Use Disorder Treatment �"
Eric Richardson, EdS; Award Winner: Young Investigator
Implementation of a Hospital Addiction Medicine Consult Liaison Service
�" Martha J. Wunsch MD, FAAP, DFASAM; Award Winner: Best Overall
Association of Self-Reported Chronic Pain and Smoking Cessation Outcomes in
Primary Care �" Andrew Thomas, MD, MPH
Award Winner: Resident
Indiana Court Employees' Attitudes towards Medication-Assisted Treatments
for OUD �" Barbara Andraka-Christou, JD, PhD; Award Winner: Associated
Michael Fingerhood, MD, DFASAM
Affiliation: Medical Director, Comprehensive Care Practice and Associate Professor of Medicine
Johns Hopkins Bayview Medical Center and Johns Hopkins University
Dr. Michael Fingerhood is an Associate Professor of Medicine at the Johns Hopkins University. He is the Chief of the Division of Chemical Dependence and medical director of the Comprehensive Care Practice (CCP) at Johns Hopkins Bayview Medical Center. The CCP integrates substance abuse treatment with primary medical care, including care for HIV and hepatitis C.
|Barbara (Basia) Andraka-Christou is an Assistant Professor at the University of Central Florida in the Department of Health Management and Informatics. She researches at the intersection of health policy, health services, and health informatics, specifically in the area of substance use disorder treatment. She has a J.D. and Ph.D. from Indiana University-Bloomington and is a licensed attorney in the state of Florida. To learn more about her research, please visit www.bandrakachristou.com.|
Seth A. Clark
|Seth Clark MD, MPH - Addiction Medicine Fellow Brown University. Received combined MD/MPH from the University of Texas Medical Branch. Completed General Internal Medicine residency, clinician educator track, and a chief resident year at Warren Alpert Medical School of Brown University. Currently participating in Addiction Medicine Fellowship at Brown University.|
Martha J. Wunsch
MD, FAAP, DFASAM
Martha J Wunsch, MD, FAAP , DFASAM is an addiction specialist with The Permanente Medical Group in Northern California. She is the Program Director for the Kaiser Addiction Medicine Fellowship and Medical Director of the San Leandro Hospital Addiction Medicine Consultation and Liaiason Service. Marty earned a medical degree at Uniformed Services University of the Health Sciences in Bethesda, Maryland, completed a pediatric internship and residency at Children’s Hospital Los Angeles (1983-1986), and practiced general pediatrics in the Indian Health Service in Arizona.
Dr. Wunsch was the Hoff Addiction Medicine Fellow at Medical College of Virginia/Virginia Commonwealth University (2000-2002). She is a distinguished fellow of the American Society of Addiction Medicine and a founding co-editor of the Journal of Addiction Medicine. Dr. Wunsch is a founding director of the American Board of Addiction and the President Elect of The Addiction Medicine Foundation.
Sean Esteban McCabe
|Sean Esteban McCabe, Ph.D., M.S.W. Co-Director and Professor, University of Michigan Center for the Study of Drugs, Alcohol, Smoking and Health Dr. McCabe is an internationally recognized scholar in the areas of epidemiology of substance use disorders, prescription medication misuse, sexuality, adolescence, and web-based data collection. He previously served as the Director of the University of Michigan Substance Abuse Research Center (UMSARC). Prior to joining UMSARC, Dr. McCabe served as the Director of the Office of Student Conflict Resolution and Assistant to the Vice President for Student Affairs at the University of Michigan. Dr. McCabe received his undergraduate education from Kenyon College and his graduate education from the University of Michigan. He has clinical experience treating adolescents, young adults and adults with substance use disorders. Dr. McCabe completed a National Institute on Drug Abuse postdoctoral fellowship at the University of Michigan. He is the Co-Director of the Center for the Study of Drugs, Alcohol, Smoking and Health (DASH) in the School of Nursing at the University of Michigan. Dr. McCabe has served as a faculty mentor on four NIH-funded substance use research training programs and he mentors undergraduate and graduate students and postdoctoral fellows. Dr. McCabe was the recipient of the University of Michigan Research Faculty Recognition Award and he has been the recipient of three NIH research awards. He served as the Associate Editor of the Journal of Addictive Diseases and reviews manuscripts for 40 health, research methods, and addiction journals. Dr. McCabe reviews grant applications for several organizations including the NIH, Department of Education, and William T. Grant Foundation. He has served as principal investigator of twelve NIH-funded projects in the past twelve years, as well as a participating investigator on a number of NIH-funded projects and he has authored or co-authored over 170 peer-reviewed articles.|
|Dr. Andrew Thomas is a second year family medicine resident at Queen's University in Ontario, Canada. He completed medical school at the Howard University College of Medicine in 2017. He has had an interest in addiction medicine (and in particular smoking cessation) for a number of years. He will be transitioning to practice this year and plans to have a mixed practice with community family medicine and outpatient addiction medicine.|
ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The American Society of Addiction Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABPM Maintenance of Certification (MOC)
The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1.5 LLSA credits towards ABPM MOC Part II requirements.
ABAM Transitional Maintenance of Certification (tMOC)
This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of 1.5 AMA PRA Category 1 Credit(s)™ for completing this course.
ABIM Maintenance of Certification (MOC)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.